The use of tocofersolan as a rescue agent in larval zebrafish exposed to benzo[a]pyrene in early development.


Journal

Neurotoxicology
ISSN: 1872-9711
Titre abrégé: Neurotoxicology
Pays: Netherlands
ID NLM: 7905589

Informations de publication

Date de publication:
09 2021
Historique:
received: 19 04 2021
revised: 25 06 2021
accepted: 12 07 2021
pubmed: 18 7 2021
medline: 5 2 2022
entrez: 17 7 2021
Statut: ppublish

Résumé

Polycyclic aromatic hydrocarbons (PAHs) are widespread environmental pollutants created by incomplete combustion. Benzo(a)pyrene (BaP), the prototypic PAH, is known to exert toxicity through oxidative stress which is thought to occur through inhibition of antioxidant scavenging systems. The use of agents that reduce oxidative stress may be a valuable route for ameliorating the adverse effects of PAHs on neural development and behavior. This study was conducted to determine if tocofersolan (a synthetic water-soluble analog of vitamin E) supplementation can prevent or reduce neurobehavioral deficits in zebrafish embryos exposed to BaP during early development. Newly hatched zebrafish were assessed on locomotor activity and light responsivity. Zebrafish embryos were exposed to vehicle (DMSO), tocofersolan (0.3 μM-3 μM), and/or BaP (5 μM) from 5-120 hours post-fertilization. This concentration range was below the threshold for producing overt dysmorphogenesis or decreased survival. One day after the end of exposure the larval fish were tested for locomotor activity under alternating light and dark 10 min periods, BaP (5 μM) was found to cause locomotor hypoactivity in larval fish. Co-exposure of tocofersolan (1 μM) restored control-like locomotor function. Based on the findings of this study, this model can be expanded to assess the outcome of vitamin E supplementation on other potential environmental neurotoxicants, and lead to determination if this rescue persists into adulthood.

Identifiants

pubmed: 34273383
pii: S0161-813X(21)00081-4
doi: 10.1016/j.neuro.2021.07.003
pmc: PMC8440378
mid: NIHMS1726138
pii:
doi:

Substances chimiques

Water Pollutants, Chemical 0
Vitamin E 1406-18-4
Benzo(a)pyrene 3417WMA06D
tocophersolan O03S90U1F2

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

78-84

Subventions

Organisme : NIEHS NIH HHS
ID : P42 ES010356
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Références

Free Radic Biol Med. 2018 Feb 20;116:149-158
pubmed: 29309894
J Mol Endocrinol. 2007 May;38(5):569-85
pubmed: 17496158
Toxicol Mech Methods. 2021 Jul;31(6):467-475
pubmed: 34027802
BMC Genomics. 2014 Oct 08;15:880
pubmed: 25297811
J Dermatol Sci. 2011 Apr;62(1):42-9
pubmed: 21316925
J Cell Biochem. 2018 Aug;119(8):6492-6500
pubmed: 29345337
Chem Biol Interact. 2002 Sep 20;141(1-2):77-95
pubmed: 12213386
Neurorehabil Neural Repair. 2010 Mar-Apr;24(3):290-8
pubmed: 19841436
Neurotoxicology. 2018 May;66:221-232
pubmed: 28935585
J Clin Pharm Ther. 2009 Oct;34(5):515-22
pubmed: 19744007
Neurotoxicol Teratol. 2017 Jan - Feb;59:27-34
pubmed: 27989697
Antioxidants (Basel). 2020 Aug 11;9(8):
pubmed: 32796530
Free Radic Res. 2004 Sep;38(9):995-1002
pubmed: 15621718
Proc Natl Acad Sci U S A. 2016 Dec 20;113(51):14835-14840
pubmed: 27930324
Neurotox Res. 2001 Nov;3(6):557-79
pubmed: 15111245
J Pediatr Gastroenterol Nutr. 2016 Dec;63(6):610-615
pubmed: 27429423
Science. 2006 Aug 25;313(5790):1093-7
pubmed: 16931756
J Appl Toxicol. 2006 Sep-Oct;26(5):427-38
pubmed: 16858674
Front Pharmacol. 2016 Aug 08;7:245
pubmed: 27551266
Environ Int. 2017 Aug;105:12-19
pubmed: 28482185
Neurotoxicology. 2011 Mar;32(2):188-98
pubmed: 21216261
Neurotoxicology. 2009 Jan;30(1):52-8
pubmed: 18952124
Free Radic Biol Med. 2017 Nov;112:308-317
pubmed: 28790013
Birth Defects Res C Embryo Today. 2013 Mar;99(1):14-23
pubmed: 23723169
J Biol Chem. 2004 Jun 4;279(23):23847-50
pubmed: 15028720
Arch Environ Contam Toxicol. 2016 Feb;70(2):311-20
pubmed: 26498942
Neurotoxicol Teratol. 2006 Jul-Aug;28(4):509-16
pubmed: 16814516
Expert Opin Drug Metab Toxicol. 2009 Apr;5(4):393-401
pubmed: 19368493
Mutat Res. 2000 Feb 16;465(1-2):151-8
pubmed: 10708981
Free Radic Biol Med. 2010 Oct 15;49(7):1147-51
pubmed: 20656021
Microvasc Res. 2021 Sep;137:104179
pubmed: 34051271
Toxicol Sci. 2015 May;145(1):5-15
pubmed: 25911656
Pediatrics. 2009 Aug;124(2):e195-202
pubmed: 19620194
Am J Physiol Regul Integr Comp Physiol. 2005 Nov;289(5):R1392-9
pubmed: 16020519
PLoS One. 2013 Nov 08;8(11):e78356
pubmed: 24260113
Cell Mol Biol (Noisy-le-grand). 2004 Sep;50(6):715-21
pubmed: 15641162
Environ Health Perspect. 2002 Jun;110 Suppl 3:451-88
pubmed: 12060843
Mutat Res Rev Mutat Res. 2015 Apr-Jun;764:64-89
pubmed: 26041267
Toxicology. 2010 May 27;271(3):83-6
pubmed: 20307623
Aquat Toxicol. 2015 Aug;165:19-30
pubmed: 26005921
Nucleic Acids Res. 2016 Dec 15;44(22):10727-10743
pubmed: 27694624
J Toxicol. 2016;2016:8606410
pubmed: 27034665
Brain Res Bull. 2009 Aug 28;80(1-2):17-21
pubmed: 19539729
Eur J Neurosci. 2004 Apr;19(7):1699-707
pubmed: 15078544
Arch Biochem Biophys. 1987 Nov 15;259(1):224-5
pubmed: 3688884
Neurochem Res. 2014 Apr;39(4):731-40
pubmed: 24584819
PLoS One. 2014 Mar 24;9(3):e92992
pubmed: 24664296
Environ Health. 2015 Feb 11;14:13
pubmed: 25971433
Sci Rep. 2015 Jun 18;5:11376
pubmed: 26087464
Neurotoxicology. 2008 Sep;29(5):846-54
pubmed: 18761371
Environ Health Perspect. 2013 Jul;121(7):825-31
pubmed: 23603068
Free Radic Biol Med. 2007 Jul 1;43(1):4-15
pubmed: 17561088
Toxicol Sci. 2012 Jan;125(1):248-61
pubmed: 21984485
Trends Neurosci. 2005 Aug;28(8):401-7
pubmed: 15982753
Chemosphere. 2008 Aug;73(1 Suppl):S295-302
pubmed: 18442843
Environ Mol Mutagen. 2002;39(2-3):119-26
pubmed: 11921179

Auteurs

Zade Holloway (Z)

Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, USA.

Andrew Hawkey (A)

Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, USA.

Helina Asrat (H)

Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, USA.

Nidhi Boinapally (N)

Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, USA.

Edward D Levin (ED)

Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, USA. Electronic address: edlevin@duke.edu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH